FIGURE
Figure 2
- ID
- ZDB-FIG-221226-187
- Publication
- Silva et al., 2022 - Therapeutic Potential of Deflamin against Colorectal Cancer Development and Progression
- Other Figures
- All Figure Page
- Back to All Figure Page
Figure 2
Effect of Deflamin on viability and MMPs of CRC cell lines HCT116, HT-29, and SW480: (A) Viability of human CRC cell lines when exposed to deflamin; (B) Analysis of cell death by apoptosis of human CRC cell lines treated with deflamin; (C) Zymographic analysis of the anti-gelatinases activity of deflamin. Statistical analysis was performed as described in the Statistical Analysis section (*, p ≤ 0.01; **, p ≤ 0.01, ***, p ≤ 0.001). |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Cancers